AntibioticsIn its bid to assist  pharmacists make available quality drugs to Nigerians, PharmAccess Foundation in partnership with Anadach Group has introduced soft loan designed to make drugs available at an affordable prices in the country.
 
Speaking during Pharmacy Industry Roundtable tagged, ‘Strengthening The Value Chain’, Country Director of PharmAccess Foundation, Ms. Njide Ndili emphasized the role of community pharmacists in ensuring quality drugs that would make patients get well now conversation around health insurance is ongoing. 
Ndili noted that the need to bring them together with a view to strengthening service delivery in the country’s healthcare sector. “PharmAccess is trying to give them access to finance and also provide technical support to help them to improve their practice.
 
“Through our Medical Credit Fund in partnership with our local Banks we are offering loans to stakeholders across healthcare value chain and at the moment we have given over 300 loans to pharmacists alone which are about $2.5 million and the repayment is 99.7 percent.”
 
She explained that all stakeholders across healthcare value chain are eligible to take up the loan, including pharmacies and hospitals. “All eligible need to work with us and take the loan through our partner banks because we don’t give loan directly. We also build capacity for those that take up the loan as value added service.
 
Corroborating her views, Business Development Director, Medical Credit Fund, Fisayo Okunsanya said that fake drugs has become a big challenge in Nigeria adding that they are working through the initiative to achieve a community where source of drugs can be  guaranteed as well as stimulate local manufacturing.
 
“The committees of Pharmacists that will ensure average Nigerians get drugs at the right price with the right quality.”
 
Appreciating such gesture, President, Pharmaceutical Society of Nigeria, PSN, Pharm Ahmed Yakasai said such initiative will help them to serve Nigerians better,
“We appreciate the modality of the loan and the interest rate is good but we are appealing that you should help us improve on it.
 
 
Source: Pharmanews
Go to top